{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:29:09Z","timestamp":1773894549360,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.hpb.2025.08.015","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:50:12Z","timestamp":1756482612000},"page":"1472-1478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hospital admission during neoadjuvant therapy for pancreatic ductal adenocarcinoma: prevalence, predictors, and prognosis"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8267-8979","authenticated-orcid":false,"given":"Patrick W.","family":"Underwood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Leuschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9743-4293","authenticated-orcid":false,"given":"Amanda K.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4931-3521","authenticated-orcid":false,"given":"Eric D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth L.","family":"Pitter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Manne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4751-0852","authenticated-orcid":false,"given":"Shafia","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9222-4321","authenticated-orcid":false,"given":"Pannaga","family":"Malalur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Mittra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Dillhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2373-8433","authenticated-orcid":false,"given":"Jordan M.","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2025.08.015_bib1","unstructured":"American Cancer Society. Cancer facts & figures 2025. Atlanta, GA. Available at: Https:\/\/Www.Cancer.Org\/Research\/Cancer-Facts-Statistics\/All-Cancer-Facts-Figures\/2025-Cancer-Facts-Figures.Html. Accessed March 25, 2025."},{"key":"10.1016\/j.hpb.2025.08.015_bib2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.hpb.2023.06.018","article-title":"National adoption of neoadjuvant chemotherapy: Paradigm shift in the treatment of pancreatic cancer","volume":"25","author":"Nassour","year":"2023","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2025.08.015_bib3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/jcm9041129","article-title":"Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: a meta-analysis of randomized controlled trials","volume":"9","author":"Cloyd","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.hpb.2025.08.015_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.23736\/S2724-5691.23.10150-X","article-title":"Neoadjuvant therapy for localized pancreatic ductal adenocarcinoma","volume":"79","author":"Brown","year":"2024","journal-title":"Minerva Surg"},{"key":"10.1016\/j.hpb.2025.08.015_bib5","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2025.08.015_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S2468-1253(22)00348-X","article-title":"Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial","volume":"8","author":"Ghaneh","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2025.08.015_bib7","unstructured":"American Cancer Society. National comprehensive cancer network clinical practice guidelines in oncololgy. Plymouth Meeting, PA. Available at: Https:\/\/Www.Nccn.Org\/Professionals\/Physician_gls\/Pdf\/Pancreatic.Pdf. Accessed March 25, 2025."},{"key":"10.1016\/j.hpb.2025.08.015_bib8","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1245\/s10434-018-6650-z","article-title":"The impact of hospital neoadjuvant therapy utilization on survival outcomes for pancreatic cancer","volume":"25","author":"Fisher","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.08.015_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejca.2021.10.023","article-title":"Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: a meta-analysis of randomised controlled trials","volume":"160","author":"van Dam","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.hpb.2025.08.015_bib10","first-page":"3009","article-title":"Patient experience and quality of life during neoadjuvant therapy for pancreatic cancer: a systematic review and study protocol","volume":"29","author":"Cloyd","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.hpb.2025.08.015_bib11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/SLA.0000000000006090","article-title":"Quality of life and real-time patient experience during neoadjuvant therapy: a prospective cohort study","volume":"279","author":"Shannon","year":"2024","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.08.015_bib12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.4251\/wjgo.v14.i6.1175","article-title":"Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: a qualitative study","volume":"14","author":"Stevens","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.hpb.2025.08.015_bib13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s12029-024-01030-w","article-title":"Patient perceptions of care coordination during neoadjuvant therapy for gastrointestinal cancers: a mixed methods analysis","volume":"55","author":"Bath","year":"2024","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.hpb.2025.08.015_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/bjs\/znac354","article-title":"Surgical resection rates after neoadjuvant therapy for localized pancreatic ductal adenocarcinoma: meta-analysis","volume":"110","author":"Brown","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2025.08.015_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12029-024-01153-0","article-title":"The association between patient-reported outcomes and surgical attrition during neoadjuvant therapy for gastrointestinal malignancies","volume":"56","author":"Shannon","year":"2024","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.hpb.2025.08.015_bib16","article-title":"Failure to undergo resection following neoadjuvant therapy for resectable pancreatic cancer: a secondary analysis of SWOG S1505","volume":"22","author":"Cloyd","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.hpb.2025.08.015_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49219-6","article-title":"Prognostic and risk factor analysis of cancer patients after unplanned ICU admission: a real-world multicenter study","volume":"13","author":"Wei","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.hpb.2025.08.015_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcrc.2020.01.027","article-title":"One-year survival in patients with solid tumours discharged alive from the intensive care unit after unplanned admission: a retrospective study","volume":"57","author":"Borcoman","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.hpb.2025.08.015_bib19","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cam4.1071","article-title":"Neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of prospective studies","volume":"6","author":"Zhan","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.hpb.2025.08.015_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12957-017-1240-2","article-title":"Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients","volume":"15","author":"Dhir","year":"2017","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.hpb.2025.08.015_bib21","article-title":"Neoadjuvant treatment for pancreatic cancer: controversies and advances","volume":"39","author":"Dias","year":"2024","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.hpb.2025.08.015_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/XCS.0000000000001277","article-title":"Textbook neoadjuvant experience: defining a novel composite outcomes measure for patients with pancreatic cancer undergoing neoadjuvant therapy","volume":"240","author":"Underwood","year":"2025","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hpb.2025.08.015_bib23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/XCS.0000000000000499","article-title":"Tolerability, attrition rates, and survival outcomes of neoadjuvant FOLFIRINOX for nonmetastatic pancreatic adenocarcinoma: intent-To-treat analysis","volume":"236","author":"Fong","year":"2023","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hpb.2025.08.015_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S2468-1253(23)00405-3","article-title":"Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial","volume":"9","author":"Labori","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2025.08.015_bib25","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.hpb.2020.11.1147","article-title":"Biliary intervention rates during neoadjuvant therapy for adenocarcinoma of the pancreatic head","volume":"23","author":"Kirkpatrick","year":"2021","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2025.08.015_bib26","doi-asserted-by":"crossref","first-page":"e1224","DOI":"10.1097\/SLA.0000000000005884","article-title":"Biliary adverse events during neoadjuvant therapy for pancreatic cancer","volume":"278","author":"Thalji","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.08.015_bib27","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1245\/s10434-019-07906-7","article-title":"Management of acute cholecystitis during neoadjuvant therapy in patients with pancreatic adenocarcinoma","volume":"26","author":"Jariwalla","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.08.015_bib28","doi-asserted-by":"crossref","first-page":"E1603","DOI":"10.1055\/a-1244-1989","article-title":"Novel risk factors for recurrent biliary obstruction and pancreatitis after metallic stent placement in pancreatic cancer","volume":"8","author":"Takeda","year":"2020","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.hpb.2025.08.015_bib29","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1002\/cncr.25465","article-title":"Obesity adversely affects survival in pancreatic cancer patients","volume":"116","author":"McWilliams","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2025.08.015_bib30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.surg.2016.09.038","article-title":"A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer","volume":"161","author":"Delitto","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2025.08.015_bib31","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1245\/s10434-021-10991-2","article-title":"Neoadjuvant chemotherapy switch in borderline resectable\/locally advanced pancreatic cancer","volume":"29","author":"Alva-Ruiz","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.08.015_bib32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1245\/s10434-024-16361-y","article-title":"Neoadjuvant treatment with changes in chemotherapy regimens according to carbohydrate antigen 19-9 level for resectable\/borderline resectable pancreatic ductal adenocarcinoma","volume":"32","author":"Hashimoto","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.08.015_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pan.2020.10.029","article-title":"Early dose reduction\/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC): a post hoc analysis of NAPOLI-1","volume":"21","author":"Chen","year":"2021","journal-title":"Pancreatology"},{"key":"10.1016\/j.hpb.2025.08.015_bib34","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1136\/gutjnl-2014-308762","article-title":"Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer","volume":"65","author":"Tol","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2025.08.015_bib35","first-page":"309","article-title":"Self-expanding metal stents (SEMS) provide superior outcomes compared to plastic stents for pancreatic cancer patients undergoing neoadjuvant therapy","volume":"3","author":"Adams","year":"2012","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.hpb.2025.08.015_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12876-023-02874-5","article-title":"Comparison of metal versus plastic stent for preoperative biliary drainage in patients with pancreatic cancer undergoing neoadjuvant therapy: a meta-analysis and systematic review","volume":"23","author":"Lyu","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.hpb.2025.08.015_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/1534735419894061","article-title":"Home-based exercise prehabilitation during preoperative treatment for pancreatic cancer is associated with improvement in physical function and quality of life","volume":"18","author":"Ngo-Huang","year":"2019","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.hpb.2025.08.015_bib38","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.pan.2020.07.411","article-title":"Prehabilitation prior to surgery for pancreatic cancer: a systematic review","volume":"20","author":"Bundred","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.hpb.2025.08.015_bib39","article-title":"Best practices for delivering neoadjuvant therapy in pancreatic ductal adenocarcinoma","author":"Cloyd","year":"2024","journal-title":"JAMA Surg"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25015916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25015916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:30:38Z","timestamp":1761903038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X25015916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1365182X25015916"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2025.08.015","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospital admission during neoadjuvant therapy for pancreatic ductal adenocarcinoma: prevalence, predictors, and prognosis","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2025.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Hepato-Pancreato-Biliary Association Inc.","name":"copyright","label":"Copyright"}]}}